Structural Heart Imaging Market Size – USD 15.2 billion in 2020, Market Growth – at a CAGR of 10.2%, Market Trends – Technological advances in structural heart imaging modalities, Increasing prevalence of structural heart diseases and fast-paced adoption of advanced structural heart imaging techniques to accelerate market growth
The global structural heart imaging market size is expected to reach USD 34.1 billion in 2028 at a CAGR of 10.2%, according to a new report by Reports and Data. Increasing prevalence of structural heart diseases, rising awareness about cardiac health, surging prevalence of lifestyle-induced diseases such as diabetes and high blood pressure, and increasing unhealthy habits such as excessive alcohol consumption and drug abuse are among some factors expected to drive global market revenue growth going ahead. Other key factors boosting market growth are technological advancements in structural heart imaging modalities, rapid adoption of advanced imaging techniques, increasing clinical trials of emerging cardiac imaging techniques, and increasing government support for healthcare RD activities. Market players’ increased focus on expanding existing product portfolio and a favorable regulatory scenario for structural heart procedures are expected to stimulate market growth in the near future.
Key companies operating in the market include:
Koninklijke Philips N.V., Boston Scientific Corporation, CryoLife, Inc., Abbott Laboratories, Siemens Healthineers GmbH, Toshiba Corporation, Medtronic Plc, CardioComm Solutions Inc., Edwards Lifesciences Corporation, Circle Cardiovascular Imaging, Inc., LivaNova PLC, Integer Holdings Corporation, HeartSciences, TomTec Imaging Systems GmbH, Micro Interventional Devices, Inc., Braile Biomédica, Lepu Medical Technology Co., Ltd., Shimadzu Corporation, 3mensio Medical Imaging BV, TTK Healthcare Limited, Pie Medical Imaging B.V., and Aran Biomedical Teoranta.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4100
For the purpose of this report, the global structural heart imaging market has been segmented based on product type, imaging modality, procedure type, application, and region:
By Product Type (Revenue, USD Billion; 2018-2028)
- Heart Valve Devices
- Transcatheter Heart Valves
- Surgical Heart Valves
- Occluders and Delivery Systems
- Annuloplasty Rings
- Others
By Imaging Modality (Revenue, USD Billion; 2018-2028)
- Echocardiogram
- Angiogram
- MRI (Magnetic Resonance Imaging)
- CT (Computed Tomography)
By Procedure Type (Revenue, USD Billion; 2018-2028)
- Transcatheter Aortic Valve Replacement (TAVR)
- Surgical Aortic Valve Replacement (SAVR)
- Transcatheter Mitral Valve Repair (TMVR)
- Left Atrial Appendage Closure (LAAC)
- Annuloplasty
- Valvuloplasty
- Others
By Application (Revenue, USD Billion; 2018-2028)
- Diagnosis
- Surgical Applications
By End-user (Revenue, USD Billion; 2018-2028)
- Hospitals
- Specialty clinics
- Cardiac centers
- Diagnostic centers
- Ambulatory surgical centers
- Catheterization laboratories
- Others
Regional analysis covers:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, France, Rest of Europe)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request for customization@ https://www.reportsanddata.com/request-customization-form/4100
Some Key Highlights From the Report:
- The heart valve devices segment is expected to dominate other product type segments in terms of revenue share during the forecast period. Growth of this segment is driven by rapidly growing number of TAVR procedures, surging adoption of TAVR techniques for their long-term durability and efficacy, and favorable regulatory policies.
- Based on imaging modality, the echocardiogram segment is expected to account for largest revenue share over the forecast years. Increasing incidence of structural and congenital heart diseases, augmented need for effective imaging and diagnosis of these diseases, rising use of echocardiograms in intraprocedural monitoring, and advantages such as real-time monitoring and high-quality images are the most crucial factors expected to fuel this segment’s growth.
- The North America structural heart imaging market accounted for largest revenue share in 2020. Market growth is driven by rising prevalence of structural and congenital heart diseases, increasing demand for advanced cardiac imaging solutions, and awareness about cardiac health.
Key Questions Answered by Stem Cell Banking Market Report
- What was the Stem Cell Banking Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2028)
- What will be the CAGR of 10% Market during the forecast period (2021-2028)?
- Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2028).
- Which manufacturer/vendor/players in the Stem Cell Banking Market was the market leader in 2021?
- Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/structural-heart-imaging-market
Thank you for reading our report. To know more about the customization of the report or further query about the report, please get in touch with us. Our team will ensure the report is well suited to your requirements.
Read More:
